Literature DB >> 10353835

Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.

M Wu1, E Maier, R Benz, R E Hancock.   

Abstract

Antimicrobial cationic peptides are prevalent throughout nature as part of the intrinsic defenses of most organisms, and have been proposed as a blueprint for the design of novel antimicrobial agents. They are known to interact with membranes, and it has been frequently proposed that this represents their antibacterial target. To see if this was a general mechanism of action, we studied the interaction, with model membranes and the cytoplasmic membrane of Escherichia coli, of 12 peptides representing all 4 structural classes of antimicrobial peptides. Planar lipid bilayer studies indicated that there was considerable variance in the interactions of the peptides with model phospholipid membranes, but generally both high concentrations of peptide and high transmembrane voltages (usually -180 mV) were required to observe conductance events (channels). The channels observed for most peptides varied widely in magnitude and duration. An assay was developed to measure the interaction with the Escherichia coli cytoplasmic membrane employing the membrane potential sensitive dye 3,5-dipropylthiacarbocyanine in the outer membrane barrier-defective E. coli strain DC2. It was demonstrated that individual peptides varied widely in their ability to depolarize the cytoplasmic membrane potential of E. coli, with certain peptides such as the loop peptide bactenecin and the alpha-helical peptide CP26 being unable to cause depolarization at the minimal inhibitory concentration (MIC), and others like gramicidin S causing maximal depolarization below the MIC. We discuss the mechanism of interaction with the cytoplasmic membrane in terms of the model of Matsuzaki et al. [(1998) Biochemistry 37, 15144-15153] and the possibility that the cytoplasmic membrane is not the target for some or even most cationic antimicrobial peptides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353835     DOI: 10.1021/bi9826299

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  197 in total

1.  Antibacterial and antimembrane activities of cecropin A in Escherichia coli.

Authors:  L Silvestro; J N Weiser; P H Axelsen
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.

Authors:  M Wu; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors:  L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 4.  The role of antimicrobial peptides in animal defenses.

Authors:  R E Hancock; M G Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide.

Authors:  C Chicharro; C Granata; R Lozano; D Andreu; L Rivas
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 6.  Peptide antibiotics.

Authors:  R E Hancock; D S Chapple
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide.

Authors:  Christopher W Kaplan; Jee Hyun Sim; Kevin R Shah; Aida Kolesnikova-Kaplan; Wenyuan Shi; Randal Eckert
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

8.  Interaction of antimicrobial peptide protegrin with biomembranes.

Authors:  David Gidalevitz; Yuji Ishitsuka; Adrian S Muresan; Oleg Konovalov; Alan J Waring; Robert I Lehrer; Ka Yee C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

Review 9.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria.

Authors:  Amir Braunstein; Niv Papo; Yechiel Shai
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.